UCL Institute of Ophthalmology



If you would like to see a full list of our academic staff with links to their IRIS research profiles see the A-Z list below.

Research within the Institute of Ophthalmology can be broadly divided into our three key research themes. To find out more about each department and the work taking place within it, please use the links below.

Cell Biology

Development, Ageing and Disease Theme

Fundamental mechanisms and discovery

There is an urgent need for new therapeutics for eye disease. We investigate the underlying biological mechanisms so we can identify new therapeutic targets and develop novel therapies. Our labs are using molecular and cellular modelling, molecular dissection techniques such as proteomics, lipidomics and metabolomics in combination with genetic studies that allows us to better understand the pathways involved so that we can develop better treatments.


Rescue, Repair and Regeneration Theme


We aim to protect and improve vision by developing effective new treatments and therapies. Our expertise lies in regenerative medicine, including gene and cell therapies, and extends to all physical, pharmaceutical and biological interventions designed to promote healthy eyesight and improve outcomes for people with eye diseases.


Visual Function and Integrative Epidemiology Theme

Seeing, Understanding and Delivering

Visual Function: Our research focusses on clinical endpoints, outcome measures and functional assessment. We work to improve sight tests and develop new methods of monitoring patients. We use visual neuroscience to understand visual function and measure the effectiveness of treatments to develop new therapies.

Integrative Epidemiology: With an expanding, ageing population and limited healthcare resources, modern approaches to healthcare must adapt and evolve. To drive this change, our work aims to inform public policy, improve outcomes for patients with eye diseases and build evidence to facilitate more individually-targeted care. We will develop more effective ways of managing chronic eye disease and build research capacity and expertise nationwide.